Vista Capital Partners’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Hold
2,153
0.02% 163
2026
Q1
$201K Hold
2,153
0.02% 153
2025
Q4
$210K Buy
+2,153
New +$204K 0.02% 142
2025
Q2
Sell
-2,956
Closed -$270K 131
2025
Q1
$270K Hold
2,956
0.03% 90
2024
Q4
$254K Hold
2,956
0.03% 100
2024
Q3
$290K Hold
2,956
0.03% 84
2024
Q2
$274K Hold
2,956
0.03% 73
2024
Q1
$275K Hold
2,956
0.03% 76
2023
Q4
$256K Sell
2,956
-21
-0.7% -$1.74K 0.03% 77
2023
Q3
$245K Buy
2,977
+21
+0.7% +$1.78K 0.04% 69
2023
Q2
$251K Hold
2,956
0.03% 79
2023
Q1
$246K Hold
2,956
0.04% 81
2022
Q4
$251K Hold
2,956
0.04% 70
2022
Q3
$223K Hold
2,956
0.04% 71
2022
Q2
$240K Hold
2,956
0.04% 68
2022
Q1
$259K Sell
2,956
-586
-17% -$49.6K 0.03% 71
2021
Q4
$320K Buy
+3,542
New +$306K 0.04% 69

Other funds holding IXJ

Vista Capital Partners's IXJ Position: Q2 2026 in Review

Vista Capital Partners held its iShares Global Healthcare ETF (IXJ) position steady in Q2 2026 at 2,153 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #163.

Vista Capital Partners first reported a position in IXJ in Q4 2021 and has held it in 17 quarters since. The position peaked at $320K in Q4 2021. 125 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Vista Capital Partners held 2,153 shares of iShares Global Healthcare ETF worth $212K as of Q2 2026.
  • Vista Capital Partners left its iShares Global Healthcare ETF share count unchanged in Q2 2026.
  • iShares Global Healthcare ETF made up 0.02% of Vista Capital Partners's portfolio in Q2 2026, its #163 holding.
  • Vista Capital Partners first reported a position in iShares Global Healthcare ETF in Q4 2021 and has held it in 17 quarters since.
  • Vista Capital Partners's iShares Global Healthcare ETF position peaked at $320K in Q4 2021.
  • 125 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Vista Capital Partners's 13F filing for Q2 2026, filed 24 Jul 2026.